BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31138701)

  • 1. Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C.
    Sim MJW; Rajagopalan S; Altmann DM; Boyton RJ; Sun PD; Long EO
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12964-12973. PubMed ID: 31138701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
    Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
    J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles.
    Pesce S; Carlomagno S; Moretta A; Sivori S; Marcenaro E
    J Immunol Res; 2015; 2015():754373. PubMed ID: 25961063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
    Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
    Front Immunol; 2022; 13():922252. PubMed ID: 35911762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
    Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
    Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.
    Graef T; Moesta AK; Norman PJ; Abi-Rached L; Vago L; Older Aguilar AM; Gleimer M; Hammond JA; Guethlein LA; Bushnell DA; Robinson PJ; Parham P
    J Exp Med; 2009 Oct; 206(11):2557-72. PubMed ID: 19858347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I-independent recognition of NK-activating receptor KIR2DS4.
    Katz G; Gazit R; Arnon TI; Gonen-Gross T; Tarcic G; Markel G; Gruda R; Achdout H; Drize O; Merims S; Mandelboim O
    J Immunol; 2004 Aug; 173(3):1819-25. PubMed ID: 15265913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
    Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
    EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
    Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
    J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans.
    Blokhuis JH; Hilton HG; Guethlein LA; Norman PJ; Nemat-Gorgani N; Nakimuli A; Chazara O; Moffett A; Parham P
    Immun Inflamm Dis; 2017 Dec; 5(4):461-468. PubMed ID: 28685972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.
    van Teijlingen NH; Hölzemer A; Körner C; García-Beltrán WF; Schafer JL; Fadda L; Suscovich TJ; Brander C; Carrington M; Evans DT; van Baarle D; Altfeld M
    AIDS; 2014 Jun; 28(10):1399-408. PubMed ID: 24785948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
    Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy.
    Kennedy PR; Chazara O; Gardner L; Ivarsson MA; Farrell LE; Xiong S; Hiby SE; Colucci F; Sharkey AM; Moffett A
    J Immunol; 2016 Dec; 197(11):4292-4300. PubMed ID: 27815424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion.
    Wang W; Erbe AK; Alderson KA; Phillips E; Gallenberger M; Gan J; Campana D; Hank JA; Sondel PM
    Cancer Immunol Immunother; 2016 Sep; 65(9):1047-59. PubMed ID: 27392940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.